Abrdn Life Sciences Investors (HQL) Competitors

Abrdn Life Sciences Investors (NYSE:HQL) and SRH Total Return Fund (NYSE:STEW) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Do institutionals & insiders hold more shares of HQL or STEW?

32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. Comparatively, 15.6% of SRH Total Return Fund shares are owned by institutional investors. 10.1% of Abrdn Life Sciences Investors shares are owned by company insiders. Comparatively, 0.1% of SRH Total Return Fund shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is HQL or STEW a better dividend stock?

Abrdn Life Sciences Investors pays an annual dividend of $1.66 per share and has a dividend yield of 11.3%. SRH Total Return Fund pays an annual dividend of $0.55 per share and has a dividend yield of 3.5%.

Which has higher valuation and earnings, HQL or STEW?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abrdn Life Sciences Investors	$39.95M	10.03	N/A	N/A	N/A
SRH Total Return Fund	N/A	N/A	N/A	N/A	N/A

Do analysts recommend HQL or STEW?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abrdn Life Sciences Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
SRH Total Return Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media favor HQL or STEW?

In the previous week, Abrdn Life Sciences Investors and Abrdn Life Sciences Investors both had 1 articles in the media. Abrdn Life Sciences Investors' average media sentiment score of 1.73 beat SRH Total Return Fund's score of 0.30 indicating that Abrdn Life Sciences Investors is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abrdn Life Sciences Investors	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
SRH Total Return Fund	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community believe in HQL or STEW?

Abrdn Life Sciences Investors received 95 more outperform votes than SRH Total Return Fund when rated by MarketBeat users.

Company	Underperform	Outperform
Abrdn Life Sciences Investors	Outperform Votes 95 68.35%	Underperform Votes 44 31.65%
SRH Total Return Fund	N/A	N/A

Is HQL or STEW more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Abrdn Life Sciences Investors	N/A	N/A	N/A
SRH Total Return Fund	N/A	N/A	N/A

Which has more volatility & risk, HQL or STEW?

Abrdn Life Sciences Investors has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, SRH Total Return Fund has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500.

Summary

Abrdn Life Sciences Investors beats SRH Total Return Fund on 6 of the 7 factors compared between the two stocks.